You are here: Industry Insights > J&J

News List

How to trump the Trump administration? For J&J, it’s putting list prices in ads before it’s forced to fiercepharma
February 24, 2019
Johnson & Johnson will put list prices in its drug TV ads. It’s the first pharma to announce that plan, self-regulating ahead of a proposed Trump administration rule that would force all pharma companies to add list prices to TV commercials.
Justice Department, SEC subpoenas put J&J's talc woes under federal microscope fiercepharma
February 24, 2019
Last month, a prominent U.S. senator asked Johnson & Johnson to turn over documents related to asbestos testing at the center of a set of lawsuits linking its iconic baby powder to cancer. But a new J&J disclosure shows it has bigger problems on its hands
Novartis’ Cosentyx beats J&J’s Stelara in psoriasis trial pharmatimes
January 17, 2018
Novartis has released trial data showing that Cosentyx was “significantly more effective” than Johnson & Johnson’s rival biologic Stelara in achieving clear skin in patients with psoriasis.